Research into conolidine has resulted in discovery of an opioid receptor in the body referred to as ACKR3/CXCR7. ACKR3 seems to be quite possibly the most popular target for conolidine, which also disregards the opposite four classical opioid receptors(three). **This can be a subjective evaluation dependant on the energy https://www.proleviate.com/post/conolidine-an-alternative-natural-pain-relief-to-replace-traditional-painkillers